Abstract
The 21st Annual International Conference on Alzheimer's Drug Discovery was held October 5–6, 2020, as a virtual event. It showcased the innovative approaches of the Alzheimer's Drug Discovery Foundation's funded scientists and their newest results. In addition to featuring the foundation's portfolio, the program also included guest presentations focusing on the latest research in the Alzheimer's disease field. The two-day program consisted of keynote lectures, invited presentations, virtual posters and a start-up forum. The five scientific sessions featured interactive presentations on Novel Approaches for Neuroinflammation; Metabolic and Mitochondrial Approaches for Alzheimer's Disease; Emerging Areas in Drug Development for Neurodegeneration; Neuroprotection, Synaptic Health and Neurotransmitters; and Novel Biomarkers in Alzheimer's Disease. The event, which drew more than 850 attendees from all over the world, was presented by the Alzheimer's Drug Discovery Foundation with additional support from Merck and Transpharmation. Recordings and additional materials remain available at the foundation's website:
Get full access to this article
View all access options for this article.